ZNF865 (BLST), a previously uncharacterized zinc finger protein, has been identified as a regulator of genomic stability and cellular senescence in the intervertebral disc. Its expression declines with age and degeneration in human and mouse discs, and experimental suppression drives senescence, DNA damage, disc degeneration, and pain behavior in rodents, while restoration reverses senescent features and restores chromatin accessibility toward a healthy state. The finding links a discrete molecular control point to both tissue aging and the clinical experience of pain.
Key Points
- ZNF865 expression declines with age and disc degeneration in humans
- Suppressing ZNF865 triggers senescence, DNA damage, and pain behavior
- Restoration reduces SASP, repairs chromatin accessibility, restores matrix production
Longevity Analysis
Chronic back pain is often treated as a structural or mechanical problem, yet here the upstream driver is the accumulation of senescent cells in a tissue with minimal regenerative reserve and poor vascular supply. A pain signal in this context reports cellular exhaustion and failed DNA repair rather than simple mechanical wear, which reframes how persistent musculoskeletal complaints should be interpreted. Reducing the load of DNA-damaging exposures and supporting repair capacity remain the practical levers available now, while targeted modulation of genome-stability regulators points toward a future in which degeneration in load-bearing tissue is addressed at its cellular origin.
Original published by Wiley Aging Cell, by Christian Lewis, Hunter Levis, Jonah Holbrook, Jacob T. Polaski, Timothy D. Jacobsen, Josh Mizels, Molly Czachor, Sarah E. Gullbrand, Brian Diekman, James C. Iatridis, Jason Gertz, Brandon Lawrence, Robby D. Bowles .